Cargando…
Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984144/ https://www.ncbi.nlm.nih.gov/pubmed/35401215 http://dx.doi.org/10.3389/fphar.2022.873197 |
_version_ | 1784682118560874496 |
---|---|
author | Egea, Javier López-Muñoz, Francisco Fernández-Capetillo, Oscar Reiter, Russel J. Romero, Alejandro |
author_facet | Egea, Javier López-Muñoz, Francisco Fernández-Capetillo, Oscar Reiter, Russel J. Romero, Alejandro |
author_sort | Egea, Javier |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8984144 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89841442022-04-07 Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies Egea, Javier López-Muñoz, Francisco Fernández-Capetillo, Oscar Reiter, Russel J. Romero, Alejandro Front Pharmacol Pharmacology Frontiers Media S.A. 2022-03-23 /pmc/articles/PMC8984144/ /pubmed/35401215 http://dx.doi.org/10.3389/fphar.2022.873197 Text en Copyright © 2022 Egea, López-Muñoz, Fernández-Capetillo, Reiter and Romero. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Egea, Javier López-Muñoz, Francisco Fernández-Capetillo, Oscar Reiter, Russel J. Romero, Alejandro Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies |
title | Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies |
title_full | Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies |
title_fullStr | Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies |
title_full_unstemmed | Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies |
title_short | Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies |
title_sort | alkylating agent-induced toxicity and melatonin-based therapies |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984144/ https://www.ncbi.nlm.nih.gov/pubmed/35401215 http://dx.doi.org/10.3389/fphar.2022.873197 |
work_keys_str_mv | AT egeajavier alkylatingagentinducedtoxicityandmelatoninbasedtherapies AT lopezmunozfrancisco alkylatingagentinducedtoxicityandmelatoninbasedtherapies AT fernandezcapetillooscar alkylatingagentinducedtoxicityandmelatoninbasedtherapies AT reiterrusselj alkylatingagentinducedtoxicityandmelatoninbasedtherapies AT romeroalejandro alkylatingagentinducedtoxicityandmelatoninbasedtherapies |